Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5774671

CCN(CCNC(=O)CCc1cnoc1-c1ccc(F)cc1)c1cccc(C)c1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.54
ALDH1A1 P00352 5/20 0.54
LMNA P02545 4/20 0.54
HTT P42858 3/20 0.54
ALOX15 P16050 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
TP53 P04637 1/20 0.41
GFER P55789 2/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 3/20 0.39
RXFP1 Q9HBX9 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.37
KCNH2 Q12809 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776374 0.93 MAPT (0.53) MAPTALDH1A1LMNAHTTALOX15
Trifluoroacetic Acid SCHEMBL5777437 0.83 ACKR3 (0.41) MAPTALDH1A1LMNAHTTALOX15
Trifluoroacetic Acid SCHEMBL5774893 0.81 GAA (0.47) MAPTALDH1A1LMNAHTTALOX15
Trifluoroacetic Acid SCHEMBL5774082 0.81 ACKR3 (0.42) MAPTALDH1A1LMNAHTTALOX15
SCHEMBL5774678 0.81 MAPT (0.42) MAPTALDH1A1LMNAHTTALOX15
Trifluoroacetic Acid SCHEMBL5775794 0.81 KCNH2 (0.38) MAPTALDH1A1LMNAHTTALOX15
Trifluoroacetic Acid SCHEMBL5774844 0.78 HDAC4 (0.40) ALDH1A1LMNAHPGDTP53KMT2A
Trifluoroacetic Acid SCHEMBL5777271 0.77 GAA (0.37) MAPTALDH1A1LMNAHTTALOX15
Trifluoroacetic Acid SCHEMBL5773568 0.75 EPHX2 (0.52) HPGDTP53KMT2AMEN1POLB
Trifluoroacetic Acid SCHEMBL5776657 0.75 MAPT (0.42) MAPTSMN1; SMN2HPGDTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MAPT 4701/4885ALDH1A1 1045/4885LMNA 2770/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MAPT 4763/4885ALDH1A1 682/4885LMNA 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.